Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53,574 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Single‑center, retrospective, evaluator‑blinded, pilot and pivotal clinical trials: Assessing the mirCaP Kit (hsv2‑miR‑H9/hsa‑miR‑3659) as a diagnostic marker for prostate cancer in patients with PSA levels in the gray zone.
Kim WT, Kim K, Kang HW, Byun YJ, Piao XM, Kim YJ, Lee SC, Yun SJ, Ha YS, Kim J, Kim IY. Kim WT, et al. Among authors: kim iy, kim yj, kim j, kim k. Oncol Lett. 2024 Oct 23;29(1):23. doi: 10.3892/ol.2024.14770. eCollection 2025 Jan. Oncol Lett. 2024. PMID: 39512501 Free PMC article.
Urinary hsv2-miR-H9 to hsa-miR-3659 ratio is an effective marker for discriminating prostate cancer from benign prostate hyperplasia in patients within the prostate-specific antigen grey zone.
Kang HW, Byun YJ, Moon SM, Kim K, Piao XM, Zheng CM, Moon SK, Choi YH, Kim WT, Kim YJ, Lee SC, Yun SJ, Kim WJ. Kang HW, et al. Among authors: kim yj, kim wj, kim wt, kim k. Investig Clin Urol. 2022 Mar;63(2):238-244. doi: 10.4111/icu.20210493. Investig Clin Urol. 2022. PMID: 35244999 Free PMC article.
COL6A1 expression as a potential prognostic biomarker for risk stratification of T1 high grade bladder cancer: Unveiling the aggressive nature of a distinct non-muscle invasive subtype.
Kim K, Byun YJ, Zheng CM, Moon S, Jo SJ, Kang HW, Kim WT, Choi YH, Moon SK, Kim WJ, Piao XM, Yun SJ. Kim K, et al. Among authors: kim wj, kim wt. Investig Clin Urol. 2024 Jan;65(1):94-103. doi: 10.4111/icu.20230227. Investig Clin Urol. 2024. PMID: 38197756 Free PMC article.
A Molecular Signature Determines the Prognostic and Therapeutic Subtype of Non-Muscle-Invasive Bladder Cancer Responsive to Intravesical Bacillus Calmette-Guérin Therapy.
Kim SK, Park SH, Kim YU, Byun YJ, Piao XM, Jeong P, Kim K, Lee HY, Seo SP, Kang HW, Kim WT, Kim YJ, Lee SC, Moon SK, Choi YH, Kim WJ, Kim SY, Yun SJ. Kim SK, et al. Among authors: kim yj, kim wj, kim sy, kim yu, kim wt, kim k. Int J Mol Sci. 2021 Feb 1;22(3):1450. doi: 10.3390/ijms22031450. Int J Mol Sci. 2021. PMID: 33535616 Free PMC article.
Expression of phosphorylated p21-activated kinase 4 is associated with aggressive histologic characteristics and poor prognosis in patients with surgically treated renal cell carcinoma.
Kang HW, Piao XM, Lee HY, Kim K, Seo SP, Ha YS, Kim YU, Kim WT, Kim YJ, Lee SC, Kim WJ, Shin EY, Kim EG, Yun SJ. Kang HW, et al. Among authors: kim yj, kim eg, kim wj, kim yu, kim wt, kim k. Investig Clin Urol. 2021 Jul;62(4):399-407. doi: 10.4111/icu.20200399. Epub 2021 May 17. Investig Clin Urol. 2021. PMID: 34085786 Free PMC article.
53,574 results
You have reached the last available page of results. Please see the User Guide for more information.